Senores Pharmaceuticals Limited has informed the Exchange about Schedule of meet
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Senores Pharmaceuticals has announced a Q4FY26 earnings conference call scheduled for May 14, 2026 at 5:00 PM IST. The call follows the announcement of the company's audited consolidated and standalone financial results for the quarter and financial year ended March 31, 2026. Company management including the Managing Director, Chairman, and Whole Time Director & CFO will participate. The call is hosted by Ambit Capital and a recording and transcript will be published on the company website afterward.
This is a routine regulatory disclosure allowing investors to participate in the post-results discussion with management. No immediate impact on the stock, but the call may provide guidance and business outlook that could influence sentiment.